OXB — Oxford BioMedica Share News
0.000.00%
- £754.25m
- £805.80m
- £128.80m
REG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementRCS - Oxford Biomedica PLC - Findings Reported by Novartis on CTL-019 at ASH <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Strategic Alliance with Orchard Therapeutics <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Grant of options <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementRCS - Oxford Biomedica PLC - Publication of RetinoStat® (OXB-201) Phase I study <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Holding(s) in Company <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC Aviva PLC - Holding(s) in Company <Origin Href="QuoteRef">AV.L</Origin> <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Admission to Trading and Total Voting Rights <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Result of General Meeting and Directors Dealing <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - Publication of Prospectus <Origin Href="QuoteRef">OXB.L</Origin>
AnnouncementREG - Oxford Biomedica PLC - FUNDRAISING OF £10 MILLION <Origin Href="QuoteRef">OXB.L</Origin> - Part 1
AnnouncementREG - Oxford Biomedica PLC - FUNDRAISING OF £10 MILLION <Origin Href="QuoteRef">OXB.L</Origin> - Part 2
AnnouncementREG - Oxford Biomedica PLC - INTERIM RESULTS FOR 6 MONTHS ENDED 30 JUNE 2016 <Origin Href="QuoteRef">OXB.L</Origin> - Part 1
Announcement